Company intelligence / Profile preview

Byonyks

Itasca, Illinois, United Statesbyonyks.com ↗

Ownership: Private
Employees: ~59
Development stage: NDA

Overview

Byonyks has developed an automated peritoneal dialysis device, "Robo-Kidney," designed to provide bloodless, home-based dialysis for patients with chronic kidney disease. The device aims to improve patient outcomes by preserving residual renal function, reducing infection risk, and making treatment more affordable. Clinical evaluation is ongoing with plans for commercial manufacturing pending regulatory approval[1][5].

Therapeutic areas: Nephrology
Modalities: DeviceNon-pharmacological therapy (Automated Peritoneal Dialysis)
Industry: Therapeutic Medical Devices

Drug pipeline

3 assets

X1

NDA

Indications: End-stage renal disease

2 more assets in the full pipeline.

Request access →

Partnerships

Ignite Pakistan (innovation funding partner)[5]

Beyond the preview

Go deeper on Byonyks.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Byonyks.

Explore the full profile